DyAnsys recently announced that its First Relief neurostimulation device received FDA clearance to treat pain from diabetic peripheral neuropathy. Palo Alto, California-based DyAnsys designed the wearable device, placed on the ear, to administer continuous pulses of low-level electrical current over several days, offering multiple treatments of up to 56 days for symptomatic relief of chronic, […]
dyansys
7 medtech stories we missed this week: June 15, 2018
From Cytosorbents opening a new U.S. manufacturing facility to DyAnsys received FDA clearance for a wearable to treat opioid withdrawals, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Cytosorbents opens new U.S. manufacturing facility CytoSorbents announced in a June 12 press release that it has opened a new […]